Mary PatGallagherMD

Pediatric Endocrinology • New York, NY

Pediatric Diabetes Endocrinology

Assistant Professor, Pediatrics, Hassenfeld Children's Hospital at NYU Langone

Join to view full profile

Dr. Gallagher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gallagher's full profile

Already have an account?

Office
135 East 31st Street
2nd Floor
New York, NY 10016
Is this information wrong?

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Endocrinology, 1999 - 2002
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 1995 - 1999
Rutgers New Jersey Medical SchoolClass of 1995

Certifications & Licensure

NY State Medical License 1998 - 2025
CT State Medical License 2005 - 2006
NJ State Medical License 2002 - 2005
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

New York Magazine: Top Doctors 2013-2022
Super Doctor SuperDoctors.com, 2009-2010, 2012-2022
Castle Connolly Top Doctors: New York Metro Area 2009-2022
Castle Connolly America's Top Doctors 2014-2019
Join now to see all

Clinical Trials

TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
Recruiting
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial Start of enrollment: 2004 May 01
Completed
Phase 2
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials Start of enrollment: 2004 Nov 01
Completed
Not Applicable
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
Completed
Phase 3
Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus Start of enrollment: 2008 Feb 01
Completed
Phase 2
Study of Antithymocyte Globulin for Treatment of New-onset T1DM Start of enrollment: 2007 Aug 01
Terminated
Phase 2
Proleukin and Rapamune in Type 1 Diabetes Start of enrollment: 2007 Aug 01
Completed
Phase 1
Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects Start of enrollment: 2009 Feb 01
Completed
Phase 2
Treatment With hOKT3gamma1(Ala-Ala) in T1DM Start of enrollment: 2002 May 01
Terminated
Phase 2
Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes Start of enrollment: 2010 Oct 01
Completed
Phase 2
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk" Start of enrollment: 2010 Aug 01
Completed
Phase 2
A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II Start of enrollment: 2010 Oct 01
Withdrawn
Phase 2
A Research Trial of Aralast in New Onset Diabetes (RETAIN) Start of enrollment: 2010 Oct 01
Terminated
Phase 1
ATG-GCSF in New Onset Type 1 Diabetes Start of enrollment: 2014 Dec 01
Completed
Phase 2
Tocilizumab (TCZ) in New-onset Type 1 Diabetes Start of enrollment: 2015 Mar 12
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

93 citations
Type 1 Diabetes and COVID-19: Preliminary Findings From a Multicenter Surveillance Study in the U.S.
Osagie Ebekozien, Nudrat Noor, Mary Pat Gallagher, G. Todd Alonso> ;Diabetes Care. 2020 Jun 5
3 citations
Concordance and Discordance in the Geographic Distribution of Childhood Obesity and Pediatric Type 2 Diabetes in New York City.
Marcela Osorio, Christian A. Koziatek, Mary Pat Gallagher, Jessie Recaii, Meryle Weinstein, Lorna E. Thorpe, Brian Elbel, David C. Lee> ;Academic Pediatrics. 2020 Apr 7
15 citations
Identifying Geographic Disparities in Diabetes Prevalence Among Adults and Children Using Emergency Claims Data.
David C. Lee, Mary Pat Gallagher, Anjali Gopalan, Marcela Osorio, Andrew J. Vinson, Stephen P. Wall, Joseph Ravenell, Mary Ann Sevick, Brian Elbel> ;Journal of the Endocrine Society. 2018 Apr 17
1 citations
iPSC-derived β cells model diabetes due to glucokinase deficiency.
Haiqing Hua, Linshan Shang, Hector Martinez, Matthew Freeby, Mary Pat Gallagher, Thomas Ludwig, Liyong Deng, Ellen Greenberg, Charles LeDuc, Wendy K Chung, Robin Golan...> ;The Journal of Clinical Investigation. 2017 Mar 1
Cortisol Levels in Children With Diabetic Ketoacidosis Associated With New-Onset Type 1 Diabetes Mellitus.
Kristen M. Williams, Pamela Fazzio, Sharon E. Oberfield, Mary Pat Gallagher, Gaya S. Aranoff> ;Clinical Pediatrics. 2017 Feb 1
81 citations
Mechanisms and Disease Associations of Haplotype-Dependent Allele-Specific DNA Methylation
Catherine Do, Charles F. Lang, John Lin, Huferesh K. Darbary, Izabela Krupska, Aulona Gaba, Lynn Petukhova, Jean-Paul Vonsattel, Mary Pat Gallagher, Robin Goland, Raph...> ;American Journal of Human Genetics. 2016 May 5
22 citations
Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes.
Rachelle Gandica, Wendy K. Chung, Liyong Deng, Robin Goland, Mary Pat Gallagher> ;Pediatric Diabetes. 2015 May 1
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.
Sosenko JM Skyler JS Beam CA Krischer JP Greenbaum CJ Mahon J Rafkin LE Matheson D Herold KC Palmer JP> ;Diabetes. 2013 Dec
The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.
Sosenko JM Skyler JS Palmer JP Krischer JP Yu L Mahon J Beam CA Boulware DC Rafkin L Schatz D Eisenbarth G> ;Diabetes Care. 2013 Sep
Pediatric diabetic ketoacidosis, fluid therapy, and cerebral injury: the design of a factorial randomized controlled trial.
Glaser NS Ghetti S Casper TC Dean JM Kuppermann N> ;Pediatr Diabetes. 2013 Sep
2 citations
iPSC-derived β cells model diabetes due to glucokinase deficiency.
Haiqing Hua, Linshan Shang, Hector Martinez, Matthew Freeby, Mary Pat Gallagher, Thomas Ludwig, Liyong Deng, Ellen Greenberg, Charles Leduc, Wendy K Chung, Robin Golan...> ;The Journal of Clinical Investigation. 2013 Jul 1
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials.
Moran A Bundy B Becker DJ DiMeglio LA Gitelman SE Goland R Greenbaum CJ Herold KC Marks JB Raskin P Sanda S Schatz D Wherrett DK Wilson DM Krischer JP S...> ;Lancet. 2013 Jun 1
Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
Kroll JL Beam C Li S Viscidi R Dighero B Cho A Boulware D Pescovitz M Weinberg A> ;J Clin Virol. 2013 Jun
127 citations
Mental Health Issues in Adolescents and Young Adults With Type 1 Diabetes Prevalence and Impact on Glycemic Control
Carrie M. Bernstein, Melissa S. Stockwell, Mary Pat Gallagher, Susan L. Rosenthal, Karen Soren> ;Clinical Pediatrics. 2013 Jan 1
Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Yu L Boulware DC Beam CA Hutton JC Wenzlau JM Greenbaum CJ Bingley PJ Krischer JP Sosenko JM Skyler JS Eisenbarth GS Mahon JL> ;Diabetes Care. 2012 Jun
Effect of rituximab on human in vivo antibody immune responses.
Pescovitz MD Torgerson TR Ochs HD Ocheltree E McGee P Krause-Steinrauf H Lachin JM Canniff J Greenbaum C Herold KC Skyler JS Weinberg A> ;J Allergy Clin Immunol. 2011 Dec
15 citations
Making progress: preserving beta cells in type 1 diabetes.
Mary Pat Gallagher, Robin Goland, Carla J. Greenbaum> ;Annals of the New York Academy of Sciences. 2011 Dec 1
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Orban T Bundy B Becker DJ DiMeglio LA Gitelman SE Goland R Gottlieb PA Greenbaum CJ Marks JB Monzavi R Moran A Raskin P Rodriguez H Russell WE Schatz D ...> ;Lancet. 2011 Jul 30
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Wherrett DK Bundy B Becker DJ DiMeglio LA Gitelman SE Goland R Gottlieb PA Greenbaum CJ Herold KC Marks JB Monzavi R Moran A Orban T Palmer JP Raskin P ...> ;Lancet. 2011 Jul 23
1 citations
Congenital Pituitary Gland Abnormalities—A Possible Association With Maternal Hyperglycemia: Two Case Reports
Alicia K. Chang, Aviva B. Sopher, Mary Pat Gallagher, Alexander G. Khandji, Sharon E. Oberfield> ;Clinical Pediatrics. 2011 Feb 21
79 citations
HLA-E–restricted regulatory CD8+ T cells are involved in development and control of human autoimmune type 1 diabetes
Hong Jiang, Steve M. Canfield, Mary Pat Gallagher, Hong H. Jiang, Yihua Jiang, Zongyu Zheng, Leonard Chess> ;The Journal of Clinical Investigation. 2010 Oct 1
8 citations
A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia
Mary Pat Gallagher, Lenore S. Levine, Sharon E. Oberfield> ;Growth Hormone & IGF Research. 2005 Jul 1
12 citations
Generalized acanthosis nigricans in an otherwise healthy young child.
Hendrik Uyttendaele, Tamara Koss, Bita Bagheri, Paul Schneiderman, Miriam E. Silfen, Mary P. Gallagher, Maria C. Garzon, Danielle Engler> ;Pediatric Dermatology. 2003 May 1
8 citations
Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves disease during pregnancy : a problem revisited
Mary Pat Gallagher, Holly C. Schachner, Lenore S. Levine, Delbert A. Fisher, Walter E. Berdon, Sharon E. Oberfield> ;The Journal of Pediatrics. 2001 Dec 1
Functions of the amygdala and related forebrain areas in attention and cognition.
Gallagher M, Schoenbaum G> ;Ann. N. Y. Acad. Sci.. 1999-06-29
Join now to see all

Professional Memberships

American Diabetes Association - ADA
Member
Endocrine Society - ENDO
Member
Pediatric Endocrine Society
Member

Hospital Affiliations

NYU Langone HospitalsNew York, New York
NYU Langone Hassenfeld and Fink Childrens CenterNew York, New York